Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 2/20 | 0.42 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 2/20 | 0.41 |
| ▸ | BMP1 | P13497 | 3/20 | 0.39 |
| ▸ | BHMT | Q93088 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 2/20 | 0.36 |
| ▸ | MMP3 | P08254 | 2/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.36 |
| ▸ | MMP7 | P09237 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16295289 | 1.00 | S1PR1 (0.42) | S1PR1S1PR3LTA4HBMP1BHMT | |
| SCHEMBL16295014 | 1.00 | S1PR1 (0.42) | S1PR1S1PR3LTA4HBMP1BHMT | |
| SCHEMBL30656951 | 0.84 | BMP1 (0.50) | BMP1MMP1MMP2MMP3 | |
| SCHEMBL21664134 | 0.82 | BMP1 (0.49) | BMP1MMP1MMP2MMP3 | |
| SCHEMBL14669802 | 0.82 | BMP1 (0.49) | BMP1MMP1MMP2MMP3 | |
| SCHEMBL24096068 | 0.81 | ECE1 (0.35) | BMP1 | |
| SCHEMBL10886294 | 0.81 | ECE1 (0.35) | BMP1 | |
| SCHEMBL8729439 | 0.81 | ECE1 (0.35) | BMP1 | |
| SCHEMBL16280988 | 0.81 | SLC1A3 (0.35) | BMP1MMP1MMP2MMP3 | |
| SCHEMBL12534395 | 0.81 | SLC1A3 (0.35) | BMP1MMP1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2106279-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | Cryobiophysica, Inc. (US) | 2009-10-07 | — | — | EP | claimed |
| US-20080179243-A1 | Stationary Phase Gradient Chromatography | HIRSH ALLEN | 2008-07-31 | — | — | US | claimed |
| WO-2008086357-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | CRYOBIOPHYSICA, INC. (US) | 2008-07-17 | — | — | WO | claimed |
| US-20240219307-A1 | APPARATUS FOR CONDUCTING CONTINUOUS INTERLEAVED ASSAYING IN A MULTI-WELL PLATE | MESO SCALE TECHNOLOGIES, LLC. (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240159766-A1 | ASSAY APPARATUSES, METHODS AND REAGENTS | MESO SCALE TECHNOLOGIES, LLC. (US) | 2024-05-16 | — | — | US | disclosed |
| US-11940385-B2 | Apparatus for conducting continuous interleaved assaying in a multi-well plate | MESO SCALE TECHNOLOGIES, LLC. (US) | 2024-03-26 | — | — | US | disclosed |
| US-11892455-B2 | Assay apparatuses, methods and reagents | MESO SCALE TECHNOLOGIES, LLC. (US) | 2024-02-06 | — | — | US | disclosed |
| US-20230357320-A1 | HELICAL STAPLED PEPTIDES AND USES THEREOF | PARABILIS MEDICINES, INC. | 2023-11-09 | — | — | US | disclosed |
| EP-1963854-B1 | ASSAY APPARATUSES, METHODS AND REAGENTS | MESO SCALE TECHNOLOGIES LLC (US) | 2021-02-03 | — | — | EP | disclosed |
| US-20210025896-A1 | Assay Apparatuses, Methods and Reagents | MESO SCALE TECHNOLOGIES, LLC. | 2021-01-28 | — | — | US | disclosed |
| US-10794914-B2 | Assay apparatuses, methods and reagents | MESO SCALE TECHNOLOGIES, LLC (US) | 2020-10-06 | — | — | US | disclosed |
| EP-2269026-A2 | ASSAY APPARATUSES, METHODS AND REAGENTS | Meso Scale Technologies, LLC (US) | 2011-01-05 | — | — | EP | disclosed |
| US-20090263904-A1 | ASSAY APPARATUSES, METHODS AND REAGENTS | MESO SCALE TECHNOLOGIES, LLC | 2009-10-22 | — | — | US | disclosed |
| WO-2009126303-A2 | ASSAY APPARATUSES, METHODS AND REAGENTS | MESO SCALE TECHNOLOGIES, LLC (US) | 2009-10-15 | — | — | WO | disclosed |
| EP-2106279-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | Cryobiophysica, Inc. (US) | 2009-10-07 | — | — | EP | disclosed |
| EP-1963854-A2 | ASSAY APPARATUSES, METHODS AND REAGENTS | Meso Scale Technologies, LLC (US) | 2008-09-03 | — | — | EP | disclosed |
| US-20080179243-A1 | Stationary Phase Gradient Chromatography | HIRSH ALLEN | 2008-07-31 | — | — | US | disclosed |
| WO-2008086357-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | CRYOBIOPHYSICA, INC. (US) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008057111-A2 | ASSAY APPARATUSES, METHODS AND REAGENTS | MESO SCALE TECHNOLOGIES, LLC (US) | 2008-05-15 | — | — | WO | disclosed |
| US-20070231217-A1 | Assay apparatuses, methods and reagents | UNITED STATES GOVERNMENT; DEFENSE THREAT REDUCTION AGENCY | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357320-A1 | HELICAL STAPLED PEPTIDES AND USES THEREOF | ESRRB, ESR1, ESRRA | S1PR1 3192/4885S1PR3 3213/4885LTA4H 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.